1Molina CA,Montaner J, Abilleira S, et al. Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke[ J]. Stroke,2001,32:1079-1084.
2Kidwell CS, Saver JL, Carneado J,et al. Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis [ J ].Stroke, 2002,33:717-724.
3Larrue V, von Kummer RR, Muller A, et al. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study ( ECASB II) [ J]. Stroke,2001,32:438-441.
4Motto C,Ciccone A,Aritzu E,et al. Hemorrhage after an acute ischemic stroke. MAST-I Collaborative Group [ J ]. Stroke, 1999, 30: 761-764.
5Broderick JP, Hagen T, Brott T, et ak. Hyperglycemia and hemorrhagic transformation of cerebral infarcts[J]. Stroke, 1995,26:484-487.
6Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group[J]. N Engl J Med, 1995,333:1581-1587.
7Adams HP. Emergent use of anticoagulation for treatment of patients with ischemic stroke[ J ]. Stroke, 2002, 33 : 856-861.
8Chen ZM,Sandercock P, Pan HC, et al. Indicatices for early aspirin use in acute ischemic stroke:a combined analysis of 40 000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. On behalf of the CAST and IST collaborative groups[J].Stroke,2000,31 : 1240-1249.
10Berger C, Fiorelli M, Steiner T, et al. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic[J]. Stroke, 2001,32:1330-1335.
